COVID-19 Vaccine Phase 1 Trial Results: Safe, Generates High Levels of Neutralizing Antibodies

  NIAID-sponsored phase 1 trial tested mRNA vaccine An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19),...

The post COVID-19 Vaccine Phase 1 Trial Results: Safe, Generates High Levels of Neutralizing Antibodies appeared first on SciTechDaily.

from SciTechDaily https://ift.tt/2CjhiW4